type here...

CATEGORIES

Press Release

LATEST

1234...12Page 3 of 12

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Eggshell-based surgical material for skull injuries

Medika Life -
A bioactive polymer-ceramic composite for fixing implants and restoring bone defects in the skull was developed by an international group of materials scientists

Global Empowerment Mission in Partnership with Bethenny Frankel’s BStrong Initiative Align with NCS Group for Texas Aid Relief During The State of Emergency

Medika Life -
The LATEST mission is bringing three relief trucks to Texas with the first truck en route from Miami to Denton (The Cross Timbers Hope Center In Denton, TX) followed by Houston, TX on Tuesday (February 23)

FDA Approves New Opioid, Olinvyk, for Intravenous Use in Hospitals

Medika Life -
the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories